In the media

Admedus Ltd readies commercial CardioCel® 3D launch

11, July, 2017

Posted In: Featured, In the media

Proactive Investors takes a look at our plans for CardioCel 3D. Read their latest article here.

> Read more

Admedus CEO Wayne Paterson interview with Proactive Investors

4, July, 2017

Posted In: Featured, In the media, Videos

Our CEO Wayne Paterson recently shared his thoughts and vision for Admedus in this interview with Proactive Investors. Watch it now.

> Read more

How to regenerate a regenerative company: CEO talks to MassDevice

4, July, 2017

Posted In: Featured, In the media

Our CEO Wayne Paterson was recently interviewed by MassDevice about the progress Admedus is making. Read the story here.  

> Read more

Long-term study indicates no calcification with CardioCel after eight years

22, August, 2016

Posted In: In the media, Uncategorized

Long-term data from a Phase II extension study for the repair of congenital heart defects in paediatrics using CardioCel shows that all patients continue to progress well, with no sign of calcification or need for repeat procedures.

> Read more

Admedus shares rise on hospital infusion pump supply deal with Arcomed

25, May, 2016

Posted In: In the media, Uncategorized

Admedus said today it won a supply contract with the new Royal Adelaide Hospital for the installation of the Arcomed chroma infusion pump systems. The supply tender includes ongoing technical and clinical support as well as consumable products for the systems over the next 5 years.

> Read more

Admedus Wins 2016 Australian Manufacturer of the Year Award

14, May, 2016

Posted In: In the media, Uncategorized

After triumphing in the Most Innovative category, Admedus also took out the night’s biggest award ‘Manufacturer of the Year’. In August 2014 Admedus opened its state-of-the-art bio-manufacturing facility in Malaga, WA, and has experienced huge success in exporting its bio-scaffold regenerative medicine product, CardioCel, since then.

> Read more

Channel 7 News – A world first treatment for HPV

22, March, 2016

Posted In: In the media, Videos, Uncategorized

> Watch the video

Admedus HSV-2 clinical results encouraging – Morgans

7, March, 2016

Posted In: In the media, Uncategorized

Morgans healthcare analyst Scott Power talks to The Australian about Admedus’s HSV-2 Phase II clinical trial results.

> Read more

Gardasil creator is testing a DNA vaccine to wipe out cancer-causing HPV virus

1, March, 2016

Posted In: In the media, Uncategorized

Professor Ian Frazer (the creator of Gardasil) is working with healthcare company Admedus to create a DNA vaccine which could be injected in people who already have HPV to stop it progressing to cervical cancer. Admedus Chief Scientific Officer Dr David Rhodes said the technology developed by Admedus in conjunction with Frazer could potentially be applied to a […]

> Read more

Performance and versatility of a new tissue engineered collagen scaffold in cardiovascular surgery

24, February, 2016

Posted In: In the media, Uncategorized

Professor Leon Neethling was published in the February 2016 edition of Pädiatrische Kardiologie (German Pediatric Cardiology) journal where he discussed the performance and versatility of CardioCel in cardiovascular surgery. First publication: Lebendige Wissenschaft, Spitzenforschung Pädiatrische Kardiologie 2016; 96-466:46-47 Posted here with kind permission of Alpha Informationsgesellschaft mbH, Germany

> Read more